Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation
Authors:
Open Access
- 1 November 2017
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (11) , 1887-1894
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor ChangeJournal of Clinical Oncology, 2013
- Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cellsHaematologica, 2011
- Management of relapse after allo-SCT for AML and the role of second transplantationBone Marrow Transplantation, 2009
- Loss of Mismatched HLA in Leukemia after Stem-Cell TransplantationNew England Journal of Medicine, 2009
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- Graft-versus-Host Reactions and the Effectiveness of Donor Lymphocyte InfusionsTransplantation and Cellular Therapy, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyBone Marrow Transplantation, 2004
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Donor Leukocyte Transfusions for Treatment of Leukemic Relapse after Bone Marrow TransplantationVox Sanguinis, 1998